Literature DB >> 5023484

Plasma growth hormone in patients with chromosomal anomalies.

R H Ruvalcaba, H C Thuline, V C Kelley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5023484      PMCID： PMC1648075          DOI： 10.1136/adc.47.252.307

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  9 in total

1.  Chromosome preparations of leukocytes cultured from human peripheral blood.

Authors:  P S MOORHEAD; P C NOWELL; W J MELLMAN; D M BATTIPS; D A HUNGERFORD
Journal:  Exp Cell Res       Date:  1960-09       Impact factor: 3.905

2.  A comparison of the effects of insulin hypoglycaemia and arginine infusion on release of human growth hormone.

Authors:  S Raiti; W T Davis; R M Blizzard
Journal:  Lancet       Date:  1967-12-02       Impact factor: 79.321

3.  Non-specificity of arginine infusion as a test for growth-hormone secretion.

Authors:  J Best; K J Catt; H G Burger
Journal:  Lancet       Date:  1968-07-20       Impact factor: 79.321

4.  The arginine provocative test: an aid in the diagnosis of hyposomatotropism.

Authors:  M L Parker; J M Hammond; W H Daughaday
Journal:  J Clin Endocrinol Metab       Date:  1967-08       Impact factor: 5.958

5.  Plasma growth hormone and insulin responses in short children.

Authors:  D A Hillman; E Colle
Journal:  Am J Dis Child       Date:  1969-06

6.  Arginine-infusion test for growth-hormone secretion.

Authors:  H W Baker; J B Best; H G Burger
Journal:  Lancet       Date:  1970-12-05       Impact factor: 79.321

7.  Hormone levels in men with extra Y chromosomes.

Authors:  P O Lundberg; J Wahlström
Journal:  Lancet       Date:  1970-11-28       Impact factor: 79.321

8.  The serum growth-hormone response to hypoglycemia in dwarfism.

Authors:  S D Frasier
Journal:  J Pediatr       Date:  1967-11       Impact factor: 4.406

9.  Arginine-initiated release of human growth hormone. Factors modifying the response in normal man.

Authors:  T J Merimee; D Rabinowtitz; S E Fineberg
Journal:  N Engl J Med       Date:  1969-06-26       Impact factor: 91.245
  9 in total
  6 in total

1.  Absence of IgA and growth hormone deficiency associated with short arm deletion of chromosome 18.

Authors:  J Leisti; S Leisti; J Perheentupa; E Savilahti; P Aula
Journal:  Arch Dis Child       Date:  1973-04       Impact factor: 3.791

2.  Growth hormone treatment in young children with Down's syndrome: effects on growth and psychomotor development.

Authors:  G Annerén; T Tuvemo; C Carlsson-Skwirut; T Lönnerholm; P Bang; V R Sara; J Gustafsson
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

3.  Growth hormone deficiency and growth hormone therapy in Ullrich-Turner-syndrome.

Authors:  O Butenandt
Journal:  Klin Wochenschr       Date:  1980-01-15

4.  Assessment of growth hormone insulin like growth factor-I axis in Down's syndrome.

Authors:  A Barreca; A Rasore Quartino; M S Acutis; P Ponzani; G Damonte; E Miani; V Balestra; G Giordano; F Minuto
Journal:  J Endocrinol Invest       Date:  1994-06       Impact factor: 4.256

5.  Growth and somatomedin responses to growth hormone in Down's syndrome.

Authors:  G Annerén; V R Sara; K Hall; T Tuvemo
Journal:  Arch Dis Child       Date:  1986-01       Impact factor: 3.791

6.  Growth hormone treatment of Turner syndrome patients with insufficient growth hormone response to pharmacological stimulation tests.

Authors:  G Massa; M Vanderschueren-Lodeweyckx; M Craen; M Vandeweghe; G van Vliet
Journal:  Eur J Pediatr       Date:  1991-05       Impact factor: 3.183
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.